{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:16:35Z","timestamp":1773418595421,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["INPRA; INCT\/MCT\/CNPq\/CAPES\/FAPs n.197 - 16\/2014"],"award-info":[{"award-number":["INPRA; INCT\/MCT\/CNPq\/CAPES\/FAPs n.197 - 16\/2014"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10096-025-05329-9","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:26:53Z","timestamp":1762262813000},"page":"487-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Turbitest: an innovative rapid test for determining in vitro susceptibility to ceftazidime-avibactam plus aztreonam in Enterobacterales"],"prefix":"10.1007","volume":"45","author":[{"given":"Nat\u00e1lia Kehl","family":"Moreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"da Silva Collar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00falia Cover","family":"Salvador","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana Preussler","family":"Mott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramon","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Orlandi","family":"Barth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afonso Lu\u00eds","family":"Barth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Caier\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"9","key":"5329_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(25)00118-5","volume":"25","author":"H Sati","year":"2025","unstructured":"Sati H, Carrara E, Savoldi A, Hansen P, Garlasco J, Campagnaro E et al (2025) The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance. Lancet Infect Dis 1473309925001185. https:\/\/doi.org\/10.1016\/S1473-3099(25)00118-5","journal-title":"Lancet Infect Dis"},{"key":"5329_CR2","unstructured":"WHO (2024) Bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Available at: https:\/\/www.who.int\/publications"},{"key":"5329_CR3","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD","year":"2024","unstructured":"GBD (2024) Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404:1199\u20131226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1","journal-title":"Lancet"},{"key":"5329_CR4","doi-asserted-by":"publisher","first-page":"1135614","DOI":"10.3389\/fmicb.2023.1135614","volume":"1","author":"A Algammal","year":"2023","unstructured":"Algammal A, Hetta HF, Mabrok M, Behzadi P (2023) Emerging multidrug-resistant bacterial pathogens superbugs: A rising public health threat. Front Microbiol 1:14:1135614. https:\/\/doi.org\/10.3389\/fmicb.2023.1135614","journal-title":"Front Microbiol"},{"key":"5329_CR5","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025247","volume":"6","author":"K Bush","year":"2016","unstructured":"Bush K, Bradford PA (2016) \u03b2-lactams and \u03b2-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med 6:a025247. https:\/\/doi.org\/10.1101\/cshperspect.a025247","journal-title":"Cold Spring Harb Perspect Med"},{"key":"5329_CR6","unstructured":"EMA (2024) Emblaveo, EMA\/140194\/2024. Available at: https:\/\/www.ema.europa.eu\/"},{"key":"5329_CR7","unstructured":"FDA (2025) Aztreonam and Avibactam Injection. Available at: www.fda.gov\/drugsatfda"},{"key":"5329_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa586","author":"M Falcone","year":"2020","unstructured":"Falcone M, Daikos GL, Tiseo G, Bassoulis D, Giordano C, Galfo V et al (2020) Efficacy of Ceftazidime-avibactam plus Aztreonam in patients with bloodstream infections caused by Metallo-\u03b2-lactamase\u2013producing Enterobacterales. Clin Infect Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa586","journal-title":"Clin Infect Dis"},{"issue":"10","key":"5329_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10081012","volume":"20","author":"C Mauri","year":"2021","unstructured":"Mauri C, Maraolo AE, Di Bella S, Luzzaro F, Principe L (2021) The revival of Aztreonam in combination with avibactam against Metallo-\u03b2-Lactamase-producing Gram-negatives: a systematic review of in vitro studies and clinical cases. Antibiotics 20(10):1012. https:\/\/doi.org\/10.3390\/antibiotics10081012","journal-title":"Antibiotics"},{"key":"5329_CR10","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.2147\/IDR.S459695","volume":"17","author":"M Szyma\u0144ski","year":"2024","unstructured":"Szyma\u0144ski M, Skiba M, Piasecka M, Olender A (2024) Synergistic effect of Ceftazidime-Avibactam with Aztreonam on Carbapenemase-Positive Klebsiella pneumoniae MBL+, NDM+. Infect Drug Resist 17:2307\u20132313. https:\/\/doi.org\/10.2147\/IDR.S459695","journal-title":"Infect Drug Resist"},{"key":"5329_CR11","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1128\/JCM.01121-14","volume":"52","author":"CD Doern","year":"2014","unstructured":"Doern CD (2014) When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J Clin Microbiol 52:4124\u20134128. https:\/\/doi.org\/10.1128\/JCM.01121-14","journal-title":"J Clin Microbiol"},{"key":"5329_CR12","doi-asserted-by":"publisher","first-page":"101128","DOI":"10.1128\/AAC.01008-17","volume":"61","author":"B Davido","year":"2017","unstructured":"Davido B, Fellous L, Lawrence C, Maxime V, Rottman M, Dinh A (2017) Ceftazidime-Avibactam and Aztreonam, an interesting strategy to overcome \u03b2-Lactam resistance conferred by Metallo-\u03b2-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa. Antimicrob Agents Chemother 61:101128. https:\/\/doi.org\/10.1128\/AAC.01008-17","journal-title":"Antimicrob Agents Chemother"},{"key":"5329_CR13","doi-asserted-by":"publisher","first-page":"e00846","DOI":"10.1128\/AAC.00846-21","volume":"18","author":"A Khan","year":"2021","unstructured":"Khan A, Erickson SG, Pettaway C, Arias CA, Miller WR, Bhatti MM (2021) Evaluation of susceptibility testing methods for Aztreonam and Ceftazidime-Avibactam combination therapy on extensively Drug-Resistant Gram-Negative organisms. Antimicrob Agents Chemother 18:65:e00846\u2013e00821. https:\/\/doi.org\/10.1128\/AAC.00846-21","journal-title":"Antimicrob Agents Chemother"},{"key":"5329_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jgar.2021.12.009","volume":"28","author":"KDO Lima","year":"2022","unstructured":"Lima KDO, De Lima AV, Rocha DADC, Sampaio SCF, Cappellano P, Sampaio JLM (2022) A simple disk pre-diffusion test to predict in vitro aztreonam\/avibactam activity against NDM-producing Klebsiella pneumoniae complex. J Glob Antimicrob Resist 28:49\u201352. https:\/\/doi.org\/10.1016\/j.jgar.2021.12.009","journal-title":"J Glob Antimicrob Resist"},{"key":"5329_CR15","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/jac\/dky483","volume":"174","author":"E Wenzler","year":"2019","unstructured":"Wenzler E, Lee M, Wu TJ, Meyer KA, Shields RK, Nguyen MH et al (2019) Performance of ceftazidime\/avibactam susceptibility testing methods against clinically relevant Gram-negative organisms. J Antimicrob Chemother 174:633\u2013638. https:\/\/doi.org\/10.1093\/jac\/dky483","journal-title":"J Antimicrob Chemother"},{"key":"5329_CR16","unstructured":"CLSI (2025) M100-ED35:2025 Performance Standards for Antimicrobial Susceptibility Testing, 35th Edition. Available at: www.clsi.org"},{"key":"5329_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr563","author":"J Monteiro","year":"2012","unstructured":"Monteiro J, Widen RH, Pignatari ACC, Kubasek C, Silbert S (2012) Rapid detection of carbapenemase genes by multiplex real-time PCR. J Antimicrob Chemother. https:\/\/doi.org\/10.1093\/jac\/dkr563","journal-title":"J Antimicrob Chemother"},{"key":"5329_CR18","unstructured":"ISO (2019) Clinical laboratory testing and in vitro diagnostic test systems\u2014Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices\u2014Part 1: Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. International Organization for Standardization. Geneva, Switzerland. Available at: https:\/\/www.iso.org\/standard\/70464.html"},{"key":"5329_CR19","unstructured":"EUCAST (2025) Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. Available at: http:\/\/www.eucast.org"},{"key":"5329_CR20","unstructured":"ISO (2007) Clinical Laboratory Testing and In Vitro Diagnostic Test Systems\u2014Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices\u2014Part 2: Evaluation of Performance of Antimicrobial Susceptibility Test Device. Available at: https:\/\/www.iso.org\/standard\/41631.html"},{"key":"5329_CR21","unstructured":"FDA (2009) Guidance for Industry and FDA-Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems. Available at: https:\/\/www.fda.gov\/"},{"key":"5329_CR22","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1128\/jcm.00859-12","volume":"50","author":"P Nordmann","year":"2012","unstructured":"Nordmann P, Dortet L, Poirel L (2012) Rapid detection of extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae. J Clin Microbiol 50:3016\u20133022. https:\/\/doi.org\/10.1128\/jcm.00859-12","journal-title":"J Clin Microbiol"},{"key":"5329_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/1469-0691.12318","volume":"20","author":"L Dortet","year":"2014","unstructured":"Dortet L, Br\u00e9chard L, Poirel L, Nordmann P (2014) Rapid detection of carbapenemase-producing Enterobacteriaceae from blood cultures. Clin Microbiol Infect 20:340\u2013344. https:\/\/doi.org\/10.1111\/1469-0691.12318","journal-title":"Clin Microbiol Infect"},{"key":"5329_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2022.102721","volume":"27","author":"PO Barth","year":"2023","unstructured":"Barth PO, Roesch EW, Lutz L, De Souza \u00c2C, Goldani LZ, Pereira DC (2023) Rapid bacterial identification by MALDI-TOF MS directly from blood cultures and rapid susceptibility testing: a simple approach to reduce the turnaround time of blood cultures. Braz J Infect Dis 27:102721. https:\/\/doi.org\/10.1016\/j.bjid.2022.102721","journal-title":"Braz J Infect Dis"},{"issue":"10","key":"5329_CR25","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.5858\/arpa.2023-0199-OA","volume":"148","author":"NK Moreira","year":"2024","unstructured":"Moreira NK, Wilhelm CM, Volpato FCZ, Barth AL, Caier\u00e3o J (2024) Detection of carbapenem resistance in Enterobacterales directly from positive blood cultures using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Arch Pathol Lab Med 148(10):1145\u20131151. https:\/\/doi.org\/10.5858\/arpa.2023-0199-OA","journal-title":"Arch Pathol Lab Med"},{"key":"5329_CR26","unstructured":"EUCAST (2021) Disk Diffusion Method for Antimicrobial Susceptibility Testing - Version 9.0. Available at: http:\/\/www.eucast.org\/"},{"key":"5329_CR27","unstructured":"EUCAST (2025) Zone diameter breakpoint tables for rapid antimicrobial susceptibility testing (RAST) directly from blood culture bottles. Version 8.0. Available at: http:\/\/www.eucast.org.\/"},{"issue":"10","key":"5329_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00588-23","volume":"61","author":"C Viguier","year":"2023","unstructured":"Viguier C, Bouvier M, Sadek M, Kerbol A, Poirel L, Nordmann P (2023) Rapid Aztreonam\/Avibactam NP test for detection of aztreonam\/avibactam susceptibility\/resistance in Enterobacterales. J Clin Microbiol 2461. https:\/\/doi.org\/10.1128\/jcm.00588-23","journal-title":"J Clin Microbiol"},{"issue":"2","key":"5329_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2024.116236","volume":"109","author":"GDS Collar","year":"2024","unstructured":"Collar GDS, Moreira NK, Becker J, Barth AL, Caier\u00e3o J (2024) Determination of aztreonam\/ceftazidime-avibactam synergism and proposal of a new methodology for the evaluation of susceptibility in vitro. Diagn Microbiol Infect Dis (2):116236. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2024.116236","journal-title":"Diagn Microbiol Infect Dis"},{"key":"5329_CR30","doi-asserted-by":"publisher","first-page":"e01647","DOI":"10.1128\/jcm.01647-22","volume":"2361","author":"H Harris","year":"2023","unstructured":"Harris H, Tao L, Jacobs EB, Bergman Y, Adebayo A, Tekle T et al (2023) Multicenter evaluation of an MIC-Based Aztreonam and Ceftazidime-Avibactam broth disk elution test. J Clin Microbiol 2361:e01647\u2013e01622. https:\/\/doi.org\/10.1128\/jcm.01647-22","journal-title":"J Clin Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05329-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:44:35Z","timestamp":1773409475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05329-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5329"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05329-9","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency declaration"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}